Trials
4 active
4 in total · 3 in the EU
What this is
- How it works
- How it works isn't classified yet
- Tested for
- CRC (Colorectal Cancer) (2 trials), Solid Tumors (2 trials), Advanced Solid Tumors, Metastatic Solid Tumors
- Main trialPhase 3
- “The purpose of this study is to evaluate the efficacy and safety of standard-of-care chemotherapy and bevacizumab with or without INCA33890 in the first-line treatment of metastatic microsatellite stable colorectal cancer.”In the company’s words, NCT07284849 on ClinicalTrials.gov
Other drugs for CRC (Colorectal Cancer)
- DostarlimabGSK · Phase 3
- PembrolizumabMerck & Co. · Phase 3
- GRT-C901Seattle Project Corporation · Phase 2/3
- GRT-R902Seattle Project Corporation · Phase 2/3
- IvonescimabAkeso · Summit Therapeutics · Phase 3
- NuvastaticNatureceuticals Sdn Bhd · Phase 3
Coming up4
- 1 Jan 2027Phase 1 trial completes · ClinicalTrials.gov
- 29 Dec 2028Phase 3 trial completes · ClinicalTrials.gov
- 3 May 2029Phase 1 trial completes · ClinicalTrials.gov
- 14 May 2029Phase 2 trial completes · ClinicalTrials.gov
Changes1
Last 90 days- 17 NovStatus changed: Not yet recruiting to Recruiting · ClinicalTrials.gov NCT07823322
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 29 Dec 2028 | A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer | |
| Phase 2Recruiting | 14 May 2029 | A Study to Evaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection and Chemotherapy | |
| Phase 1Recruiting | 1 Jan 2027 | A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation | |
| Phase 1Recruiting | 3 May 2029 | A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026